{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

6th Annual MSK Symposium on Lymphoma


6th Annual MSK Symposium on Lymphoma Banner

  • Overview
  • Brochure
  • Faculty
  • Schedule
  • Support
Add to Calendar 6th Annual MSK Symposium on Lymphoma 5/13/2022 7:45:00 AM 5/14/2022 1:20:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=35525 Description: Dr. Gilles Salles welcomes you to the 6th Annual MSK Symposium on Lymphoma. This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will address the clinical management of the most frequent lymphoma entities, we will feature focused ... Online false MM/DD/YYYY


Date & Location
Friday, May 13, 2022, 7:45 AM - Saturday, May 14, 2022, 1:20 PM, Online

Specialties
Specialties - Bone Marrow Transplant, Cellular Therapeutics, Hematology, Immunotherapy, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nuclear Medicine, Oncology and Hematology

Overview

Dr. Gilles Salles welcomes you to the 6th Annual MSK Symposium on Lymphoma.

This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will address the clinical management of the most frequent lymphoma entities, we will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss during a panel how to best approach patients’ situations. We will also cover in a special session recent advances in the biology of lymphoma and how this will translate to innovative therapeutic interventions. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biomarkers and imaging into clinical practice and clinical trials.

Who Should Attend

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

Objectives
  1. Describe recent refinements in lymphoma classification
  2. Discuss first line treatment options in most frequent lymphoma entities
  3. Identify risks/benefits of new approved agents
  4. Implement standard of care changes for patients with lymphoma
  5. Educate patients on the disease and treatment options

Registration

Live Virtual Registration Fees

  • Physicians (MDs, PhDs and DOs): $200
  • Nurses, PAs and Other Healthcare Professionals: $50
  • Residents and Fellows: $50
  • Industry Professionals*: $350

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

  • A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact cme@mskcc.org for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify cme@mskcc.org.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 7:00 AM on May 13, 2022. If you wish to register after this date, please email cme@mskcc.org and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course. 

Cancellation Policy

If you wish to cancel your participation in this course, you must email cme@mskcc.org at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting cme@mskcc.org with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME (cme@mskcc.org). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



Keywords: ABIM MOCAMA PRA Category 1



MSK Course Director

Gilles Salles, MD, PhD
Chief, Lymphoma Service

 

MSK Course Planning Committee

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Steven Horwitz, MD
Attending
Lymphoma Service

Andrew Intlekofer, MD
Assistant Attending
Lymphoma Service

Ariela Noy, MD
Attending
Lymphoma Service

David Qualls, MD
Medical Oncology/Hematology Fellow

Hans-Guido Wendel, MD
Member/Professor
Cancer Biology and Genetics Program

Joachim Yahalom, MD
Attending
External Beam Radiotherapy Service

Andrew D. Zelenetz, MD, PhD 
Medical Director, Quality Informatics

 

Invited Course Faculty 

Ranjana Advani, MD
Saul Rosenberg Professor of Lymphoma
Stanford University
Stanford, CA

Stephen Ansell, MD, PhD
Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research
Chair, Lymphoma Group 
Mayo Clinic
Rochester, MN

Renier Brentjens, MD, PhD
Deputy Director
Chair, Department of Medicine
Professor of Oncology, Departments of Medicine & Immunology 
Katherine Anne Gioia Endowed Chair of Medicine
Buffalo, NY

Jaehyuk Choi, MD
Associate Professor
Feinberg School of Medicine
Chicago, IL

Ming Du, MB, PhD
Professor
University of Cambridge
United Kingdom

Thomas Habermann, MD
Hematologist
Mayo Clinic
Rochester, MN

Eric Hsi, MD
Professor and Chair
Department of Pathology
Wake Forest School of Medicine
Winston-Salem, NC

Peter Johnson, MD
Professor of Medical Oncology
University of Southampton
United Kingdom

Brad Kahl, MD
Professor
Washington University School of Medicine
St. Louis, MO

Ann LaCasce, MD, MMSc
Associate Professor of Medicine, Program Director 
Dana-Farber/Mass General Brigham Fellowship in Hematology Oncology
Boston, MA

Franck Morschhauser, MD, PhD
Professor of Hematology
Universite of Lille, CHU Lille
France

Sattva Neelapu, MD
Professor
The University of Texas MD Anderson Cancer Center 
Houston, TX

Tycel Phillips, MD
Clinical Associate Professor
University of Michigan
Ann Arbor, MI

Vincent Rajkumar, MD
Edward W. and Betty Knight Scripps Professor of Medicine
Mayo Clinic
Rochester, MN

Mark Roschewski, MD
Senior Clinician
National Cancer Institute
Bethesda, MD

Karin Tarte, PhD, PharmD
Director, Professor
Rennes Medical School
France

Jason Westin, MD, MS
Director, Lymphoma Clinical Research 
Section Chief, Aggressive Lymphoma
The University of Texas MD Anderson Cancer Center
Houston, TX

Roberta Zappasodi, PhD
Assistant Professor of Hematology in Medicine
Weill Cornell Medicine
New York, NY

 

MSK Course Faculty

 Connie Lee Batlevi, MD, PhD
Assistant Attending
Lymphoma Service

Philip C. Caron, MD, PhD
Attending
Lymphoma Service

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Zachary Epstein-Peterson, MD
Assistant Attending
Lymphoma Service

Lorenzo Falchi, MD
Assistant Attending
Lymphoma Service

Audrey M. Hamilton, MD
Laboratory Director, MSK Basking Ridge
Attending 
Lymphoma Service

Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care
Associate Attending
Lymphoma Service

Brandon Imber, MD, MA
Assistant Attending 
External Beam Radiotherapy Service

Andrew Intlekofer, MD
Assistant Member
Human Oncology & Pathogenesis Program

William Johnson, DO
Assistant Attending
Lymphoma Service

Niloufer Khan, MD, MS
Assistant Attending
Lymphoma Service

Anita Kumar, MD
Assistant Attending
Lymphoma Service

Jennifer K. Lue, MD
Assistant Attending
Lymphoma Service

Anthony Mato, MD, MSCE
Director, CLL Program
Associate Attending
Leukemia Service 

Matthew J. Matasar, MD
Associate Attending
Hematology/Lymphoma Services

Marius E. Mayerhoefer, MD, PhD
Attending
Body Imaging/Molecular Imaging and Therapy Services

Alison Moskowitz, MD
Clinical Director, Lymphoma
Associate Attending
Lymphoma Service

Colette N. Owens, MD
Assistant Attending
Lymphoma/Genitourinary Oncology Services

M. Lia Palomba, MD
Attending
Lymphoma Service

Leonard Saltz, MD
Executive Director, Clinical Value & Sustainability
Head, Colorectal Oncology Section
Attending
Gastrointestinal Oncology Service

David J. Straus, MD
Attending
Lymphoma Service

Robert Stuver, MD
Medical Oncology/Hematology Fellow

Beatriz Wills Sanin, MD
Chief Fellow, Hematology 

Santosha Vardhana, MD
Assistant Attending
Lymphoma Service 


Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Gilles Salles, MD, PhD
MSK
Activity Director, Faculty
Advisor-Abbvie|Honoraria-Bayer Corporation (Relationship has ended)|Review Panel Member-Beigene|Advisor-Bristol-Myers Squibb|Consulting Fee-Epizyme (Relationship has ended)|Advisor-Genentech, Inc.|Advisor-Genmab|Advisor-Incyte Corporation|Advisor-Janssen (Relationship has ended)|Honoraria-Gilead (Relationship has ended)|Consulting Fee-Loxo|Consulting Fee-Milteniy|Consulting Fee-Morphosys (Relationship has ended)|Consulting Fee-Novartis AG (Relationship has ended)|Consulting Fee-RAPT (Relationship has ended)|Honoraria-Regeneron (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Molecular Partners AG|Paid consultant-IPSEN (Relationship has ended)|Advisor-Velosbio (Relationship has ended)|Consulting Fee-Debiopharm (Relationship has ended)
Andrew Intlekofer, MD
MSK
Conflict of Interest Peer Reviewer, Faculty, Planner
Nothing to disclose
Ranjana Advani, MD
Stanford University
Faculty
Advisor-Kura (Relationship has ended)|Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-ADCTheraputics (Relationship has ended)|Advisor-Karyopharm (Relationship has ended)|Advisor-Bristol-Myers Squibb (Relationship has ended)|Advisor-Daiichi Sankyo (Relationship has ended)|Advisor-Epizyme, Inc (Relationship has ended)|Advisor-Incyte Corporation (Relationship has ended)|Advisor-BeiGene, Ltd (Relationship has ended)|Advisor-Gilead (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Grant or research support-Regeneron|Grant or research support-Seattle Genetics|Grant or research support-Cyteir|Grant or research support-Merck and Company, Inc.|Grant or research support-Gilead|Grant or research support-Millennium Pharmaceuticals, Inc.
Stephen M Ansell, MD, PhD
Mayo Clinic
Faculty
Grant or research support-Bristol-Myers Squibb|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-AstraZeneca|Grant or research support-Pfizer, Inc.|Grant or research support-SeaGen|Grant or research support-ADC Therapeutics
Connie Lee Batlevi, MD, PhD
MSK
Faculty
Grant or research support-Epizyme, Autolus,Roche, Vincerx|Advisor-Bristol-Myers Squibb, Seattle Genetics, Kite, Karyopharm, TG Therapeutics, ADC Therapeutics, Abbvie, Genentech|Stocks or stock options, excluding diversified mutual funds-Bristol-Myers Squibb, Pfizer, Viatris, Regeneron, Novavax, Moderna
Renier Brentjens, MD, PhD
Roswell Park Comprehensive Cancer Center
Faculty
Royalties or Patent Beneficiary-Bristol-Myers Squibb|Royalties or Patent Beneficiary-Caribou|Royalties or Patent Beneficiary-Sanofi-Aventis|Grant or research support-Bristol-Myers Squibb|Consulting Fee-Gracell Biotechnologies (Relationship has ended)|Consulting Fee-Atara Biotherapeutics, Inc.
Philip C Caron, MD,PhD
MSK
Faculty
Nothing to disclose
Jaehyuk Choi, MD, PhD
Northwestern University
Faculty
Consulting Fee-Nira Therapeutics|Consulting Fee-kyowa-kirin (Relationship has ended)
Ming Du, MB, PhD
University of Cambridge
Faculty
Nothing to disclose
Zachary D Epstein-Peterson, MD
MSK
Faculty
Nothing to disclose
Faculty Photos
Lorenzo Falchi, MD
MSK
Faculty
Grant or research support-Genmab|Consulting Fee-Genmab|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Consulting Fee-Abbvie|Advisor-ADC Therapeutics
Thomas Habermann, MD
Mayo Clinic
Faculty
Advisor-Seagen|Advisor-Tess|Advisor-Eli Lilly and Company|Advisor-Morphosys|Advisor-Incyte Corporation|Advisor-Biegene|Advisor-Loxo
Audrey Hamilton, MD
MSK
Faculty
Nothing to disclose
Paul A Hamlin, MD
MSK
Faculty
Grant or research support-Portola Pharmaceuticals, Inc.|Consulting Fee-Juno Pharmaceuticals (Relationship has ended)|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Sandoz (Relationship has ended)|Consulting Fee-Celgene (Relationship has ended)|Advisor-Calithera|Consulting Fee-Karyopharm (Relationship has ended)|Grant or research support-Janssen |Grant or research support-Molecular Templates
Eric Hsi, MD
Wake Forest School of Medicine
Faculty
Advisor-Cytomx (Relationship has ended)|Advisor-Astellas (Relationship has ended)
Brandon Imber, MD
MSK
Faculty
Honoraria-GT Medical Technologies (Relationship has ended)
Peter Johnson, MD
University of Southampton
United Kingdom
Faculty
Advisor-Incyte Corporation (Relationship has ended)|Honoraria-Epizyme (Relationship has ended)
William Johnson, DO
MSK
Faculty
Nothing to disclose
Brad Kahl, MD
Washington University School of Medicine in St. Louis
Faculty
Consulting Fee-Abbvie|Consulting Fee-ADCT Therapeutics|Consulting Fee-AstraZeneca|Consulting Fee-Beigene|Consulting Fee-Celgene|Consulting Fee-Epizyme|Consulting Fee-Genentech, Inc.|Consulting Fee-Pharmacyclics, Inc.|Consulting Fee-Roche|Consulting Fee-TG Therapeutics|Consulting Fee-Medeikon Corporation|Consulting Fee-MEI Pharma
Niloufer Khan, MD
MSK
Faculty
Grant or research support-Seattle Genetics
Anita Kumar, MD
MSK
Faculty
Advisor-AstraZeneca (Relationship has ended)|Advisor-Kite Pharmaceuticals (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Grant or research support-Seattle Genetics|Grant or research support-Adaptive Biotechnologies|Grant or research support-Loxo Biotechnologies |Grant or research support-Celgene
Ann S LaCasce, MD
Dana-Farber Cancer Institute
Faculty
Speakers Bureau-Research to Practice
Jennifer K Lue, MD
MSK
Faculty
Consulting Fee-AstraZeneca (Relationship has ended)|Honoraria-Sanofi-Aventis (Relationship has ended)
Matthew Matasar, MD
MSK
Faculty
Stocks or stock options, excluding diversified mutual funds-Merck and Company, Inc.|Honoraria-Genentech, Inc.|Honoraria-Roche|Honoraria-GlaxoSmithKline|Honoraria-Bayer Corporation|Honoraria-Pharmacyclics, Inc.|Honoraria-Janssen|Honoraria-Seattle Genetics|Honoraria-Immunovaccine Technologies|Honoraria-Takeda Pharmaceuticals, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Bayer Corporation|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Juno Therapeutics|Consulting Fee-Roche|Consulting Fee-TEVA|Consulting Fee-Rocket Medical|Consulting Fee-Seattle Genetics|Consulting Fee-Daiichi Sankyo|Consulting Fee-Takeda Pharmaceuticals, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Grant or research support-IGM Biosciences|Grant or research support-Bayer Corporation|Grant or research support-PHarmacyclis|Grant or research support-Janssen|Grant or research support-Rocket Medical|Grant or research support-Seattle Genetics|Grant or research support-Immunovaccine Technologies
Anthony Mato, MD, MSCE
MSK
Faculty
Nothing to disclose
Marius Mayerhoefer, MD, PhD
MSK
Faculty
Speakers Bureau-GE Healthcare Bio-Sciences (Relationship has ended)
Franck Morschhauser, MD
Universite of Lille, CHU Lille
Faculty
Advisor-AstraZeneca|Advisor-Roche|Advisor-Abbvie|Advisor-Gilead|Advisor-Novartis AG|Advisor-Bristol-Myers Squibb|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-Roche|Paid consultant-Abbvie|Advisor-Miltenyi
Alison Moskowitz, MD
MSK
Faculty
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed
Sattva S Neelapu, MD
The University of Texas MD Anderson Cancer Center
Faculty
Advisor-Kite/Gilead, Merck, Novartis, Sellas Life Sciences, Athenex, Allogene, Incyte, Adicet Bio, Calibr, BMS, Bluebird Bio, Sana Biotechnology|Grant or research support-Kite/Gilead, BMS, Cellectis, Poseida, Allogene, Unum Therapeutics, Precision Biosciences, Adicet Bio
Colette Owens, MD
MSK
Faculty
Nothing to disclose
Lia Palomba, MD
MSK
Faculty
Advisor-Synthekine (Relationship has ended)|Advisor-MustangBio (Relationship has ended)|Advisor-Novartis AG (Relationship has ended)|Advisor-BeiGene (Relationship has ended)
Tycel Phillips, MD
University of Michigan
Faculty
Advisor-Abbvie|Grant or research support-Abbvie|Advisor-Genentech, Inc.|Grant or research support-Bayer Corporation|Advisor-Bayer Corporation|Advisor-Incyte Corporation|Grant or research support-Incyte Corporation|Advisor-Bristol-Myers Squibb|Grant or research support-Bristol-Myers Squibb|Advisor-AstraZeneca|Advisor-ADC therapeutics (Relationship has ended)|Advisor-Eli Lilly and Company|Advisor-Pharmacyclics, Inc.|Advisor-TG therapeutics|Advisor-Epizyme
Vincent Rajkumar, MD
Mayo Clinic
Faculty
Nothing to disclose
Mark Roschewski, MD
National Cancer Institute
Faculty
Nothing to disclose
Leonard B Saltz, MD
MSK
Usa
Faculty
Advisor-Genor Biopharma Ltd.
David J Straus, MD
MSK
Faculty
Nothing to disclose
Robert Stuver, MD
MSK
Faculty
Nothing to disclose
Karin Tarte, PhD
Rennes Medical School
Faculty
Honoraria-Bristol-Myers Squibb (Relationship has ended)|Independent Contractor (included contracted research)-Sanofi-Aventis (Relationship has ended)
Santosha Vardhana, MD, PhD
MSK
Faculty
Advisor-Immunai|Consulting Fee-ADC Therapeutics
Jason Westin, MD, MS
The University of Texas MD Anderson Cancer Center
Faculty
Advisor-Gilead|Advisor-Bristol-Myers Squibb|Advisor-Novartis AG|Advisor-Incyte Corporation|Advisor-Genentech, Inc.|Advisor-Merck and Company, Inc.|Advisor-ADC Therapeutics|Advisor-Umoja|Advisor-MonteRosa
Beatriz wills, MD
MSK
Faculty
Grant or research support-Bristol-Myers Squib Aventis
Roberta Zappasodi, other
Weill Cornell Medicine
Faculty
Consulting Fee-Leap Therapeutics (Relationship has ended)|Advisor-iTEOS|Grant or research support-AstraZeneca|Grant or research support-Bristol-Myers Squibb
Ahmet Dogan, MD, PhD
MSK
Faculty, Planner
Consulting Fee-EUSA Pharma (Relationship has ended)|Consulting Fee-Loxo (Relationship has ended)|Consulting Fee-Incyte Corporation (Relationship has ended)|Grant or research support-Roche|Grant or research support-Takeda Pharmaceuticals, Inc.
Steven Horwitz, MD
MSK
Faculty, Planner
Grant or research support-Kyowa|Consulting Fee-Kyowa|Grant or research support-Affimed|Consulting Fee-Affimed|Consulting Fee-TUBULIS|Grant or research support-Takeda Pharmaceuticals, Inc.|Consulting Fee-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Secura|Consulting Fee-Secura|Consulting Fee-Ono|Grant or research support-Daiichi Sankyo|Consulting Fee-Daiichi Sankyo (Relationship has ended)|Consulting Fee-Myeloid Therapeutics (Relationship has ended)|Consulting Fee-Acrotech (Relationship has ended)|Grant or research support-Crispr|Grant or research support-Trillium|Consulting Fee-Trillium (Relationship has ended)|Grant or research support-C4
Ariela Noy, MD
MSK
Faculty, Planner
Consulting Fee-Epizyme|Consulting Fee-Janssen|Other: Research funding-Pharmacyclics, Inc.|Other: Research funding-Rafael Pharma|Advisor-Morphosys (Relationship has ended)
David Qualls, MD
MSK
Faculty, Planner
Nothing to disclose
Hans-Guido Wendel, MD
MSK
Faculty, Planner
Grant or research support-AstraZeneca
Joachim Yahalom, MD
MSK
Faculty, Planner
Stocks or stock options, excluding diversified mutual funds-Convergent
Andrew D Zelenetz, MD, PhD
MSK
Faculty, Planner
Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-MEI Pharma|Grant or research support-MEI Pharma|Advisor-Bristol-Myers Squib Aventis|Consulting Fee-Gilead|Consulting Fee-AstraZeneca|Grant or research support-Beigene|Consulting Fee-Beigene|Advisor-Sandoz (Relationship has ended)|Consulting Fee-Novartis AG|Consulting Fee-AMGEN (Relationship has ended)|Advisor-Janssen|Consulting Fee-Abbvie|Consulting Fee-Adaptive Biotechnology|Consulting Fee-MorphoSys|Other: DMC Member-Bristol Myers Squibb/Celgene/Juno

Friday, May 13, 2022
Relevant Financial Relationships
7:45AM - 7:50AM

To view faculty disclosures, please visit the course website, mskcc.org/LymphomaSymposium, and select the 'Faculty' tab. All relevant financial relationships have been mitigated prior to the commencement of the activity.
SYLLABUS DISCLAIMER
7:50AM - 7:55AM

Please note only the presentations from faculty that have given their consent will be available below:


Plenary Lecture: Circulating Tumor DNA in Lymphoma: Principles Learned and Future Directions
8:00AM - 9:00AM
Mark Roschewski, MD
Follicular Lymphoma Microenvironment: What About Stromal Cell Origin and Function?
9:00AM - 9:20AM
Karin Tarte, PhD
The Role of PD1 in Cutaneous T Cell Lymphomas
9:20AM - 9:40AM
Jaehyuk Choi, MD, PhD
Understanding Immunotherapy Resistance of B-cell Non-Hodgkin Lymphomas
9:40AM - 10:00AM
Roberta Zappasodi, other
Strategies to Overcome Immunological Barriers in the Microenvironment in Lymphoma
10:00AM - 10:20AM
Stephen M Ansell, MD, PhD
Novel Targets for Imaging of Lymphoma and Microenvironment
10:30AM - 11:00AM
Marius Mayerhoefer, MD, PhD
Building on R-CHOP to Improve DLBCL Outcomes
11:15AM - 11:35AM
Franck Morschhauser, MD
Chipping Away at CHOP: Can First Line Therapy Really be Chemotherapy Free?
11:35AM - 11:55AM
Jason Westin, MD, MS
Recent Concepts in DLBCL/High Grade B-cell Lymphomas
12:05PM - 12:25PM
Eric Hsi, MD
Personalizing First Line Therapy in Patients with Follicular Lymphoma
12:55PM - 1:15PM
Gilles Salles, MD, PhD
Options for Managing R/R Follicular Lymphoma
1:15PM - 1:35PM
Brad Kahl, MD
New Directions for the Frontline treatment of MCL
1:45PM - 2:00PM
Anita Kumar, MD
Unmasking the Boogie Man: Novel Treatment Outpatients in R/R Mantle Cell Lymphoma
2:00PM - 2:15PM
Tycel Phillips, MD
New Therapeutic Approaches in T-cell Lymphoma
2:25PM - 2:45PM
Robert Stuver, MD
Steven Horwitz, MD
Improving BTK and PI3K Inhibitors
2:50PM - 3:05PM
Andrew D Zelenetz, MD, PhD
CLL: State-of-the-Art Management and Recent Innovations
3:20PM - 3:50PM
Anthony Mato, MD, MSCE
The High Cost of Cancer Drugs and What We Need to Do About It
3:50PM - 4:15PM
Vincent Rajkumar, MD
Roundtable Discussion
4:15PM - 4:30PM
Vincent Rajkumar, MD
Paul A Hamlin, MD (Moderator)
Leonard B Saltz, MD
Steven Horwitz, MD
Gilles Salles, MD, PhD
Managing Waldenström Macroglobulinemia in 2022
4:30PM - 4:45PM
Lia Palomba, MD
CTCL: Current Management and Future Directions
4:45PM - 5:00PM
Niloufer Khan, MD
Bispecific Antibodies in B-cell Lymphoma: A New Breakthrough?
5:00PM - 5:20PM
Lorenzo Falchi, MD
David Qualls, MD
Saturday, May 14, 2022
New Frontiers for Radiotherapy in Lymphoma: Doing More with Less and Doing More with More
8:15AM - 8:45AM
Brandon Imber, MD
Recent Advances in the Biology of MALT Lymphoma
8:45AM - 9:00AM
Ming Du, MB, PhD
Options for First Line Management of Marginal Zone Lymphoma
9:00AM - 9:15AM
Thomas Habermann, MD
Considerations for Relapsed and Refractory Marginal Zone Lymphoma
9:15AM - 9:30AM
Ariela Noy, MD
Optimizing Therapy in Early Stage Classic Hodgkin Lymphoma
9:40AM - 9:55AM
Ann S LaCasce, MD
Advanced Stage Hodgkin Lymphoma: What Now?
9:55AM - 10:10AM
Peter Johnson, MD
Updates in Management of Relapsed and Refractory Hodgkin Lymphoma
10:20AM - 10:40AM
Alison Moskowitz, MD
Beatriz wills, MD
CNS Prophylaxis in DLBCL: Navigating New Data
11:00AM - 11:30AM
Ranjana Advani, MD
CAR T Cell Therapy for Transplant Eligible and Ineligible
11:30AM - 11:45AM
Sattva S Neelapu, MD
Early Relapse DLBCL: CAR T Cell for Selected Patients
11:45AM - 12:00PM
Andrew D Zelenetz, MD, PhD
Driving CAR T cells Forward
12:05PM - 12:25PM
Renier Brentjens, MD, PhD
Plenary Lecture: Adaptive Immune Dysregulation in Cancer Patients During SARS-CoV-2 Infection and Vaccination
12:25PM - 1:15PM
Santosha Vardhana, MD, PhD

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

AstraZeneca
Kite, a Gilead Company
MorphoSys US, Inc.
Janssen Research & Development, LLC


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center

Navigation Panel Toggle
Sign InLive CoursesOn Demand eLearning Coming SoonVisiting UsAboutResources & PoliciesHelp